We're Working to Win the Fight Against Skin Cancer

At AlderMed™, we believe the fight against skin cancer can be won. We are innovating new ways to advance the treatment and management of non-melanoma skin cancer by bringing Superficial Radiotherapy Treatment (“SRT”) to the front lines of patient care — in the Dermatologist’s and the Plastic Reconstructive Surgeons' practices. Now, with AlderMed's Cancer Care Treatment services, Dermatologists and Plastic Reconstructive Surgeons can offer their patients broader treatment options that deliver better care and retain the patient referrals and loyalty over the long-term.

The clinical efficacy of SRT as a non-surgical alternative for basal and squamous cell carcinomas is well established, demonstrating high cure rates, low recurrence rates, and no scarring. AlderMed is founded and owned by a team of people that believe it is vital to make SRT more broadly accessible and to build greater awareness about its benefits. We not only want to offer new hope and better outcomes for skin cancer patients everywhere but are willing to prove on our dime.

AlderMed provides an innovative approach to advancing the treatment and management of skin cancer by offering Dermatologists and Plastic Reconstructive Surgeons a cost-effective service model to bring SRT into their practice. Doing this allows them to provide their patients with point-of-care treatments that produce high cure rates, low recurrence rates, and no scars. This service model enables Dermatologists and Plastic Reconstructive Surgeons to deliver better patient care and retain the patient referrals and loyalties while increasing the value of their practice.

The Company exclusively uses the Xstrahl 100 system for the non-surgical treatment of non-melanoma skin cancers. The Xstrahl is based on patented technology that provides a unique, minimally invasive and competitive advantage. The system is a fully portable and self-shielding device, making it an excellent choice for AlderMed's service model. Formed in 2011, AlderMed is headquartered in Carson City, Nevada with offices in California and Oregon. To learn more about the company, its service model and superficial radiation therapy treatment visit www.AlderMed.com.

All Employees are Owners

AlderMed intends on creating corporations in each state that we service. The corporations will serve as staffing agencies and will be majority owned and operated by AlderMed. The “Director” of each corporation will manage the clients, Registered Radiation Therapist (“RRT”), Dosimetrist, Medical Physicist, and service personnel, who are responsible for the delivery of our services in their respective state. Everyone will own shares of stock in their corporation allowing the Employee Stock Option Plan to reward performance for long-term customer satisfaction. In the event of a buyout, every employee stock owner will be rewarded for the Company’s national level of performance calibrated to their corporation’s actual contribution. All investors will own preferred stock in No Scar SRT, Inc. (AlderMed LLC is a disregarded entity that manages all of the state corporations for a fee that equates to everything above the state corporation’s cost and provides asset protection for NSSRT, Inc.)

Mission Statement

AlderMed™ is committed to being the leader in non-surgical treatment for non-melanoma skin cancers. We offer the Dermatologists and Plastic Reconstructive Surgeons a cost-effective model to bring Superficial Radiation Treatment (“SRT”) into their practice, providing their patients with point-of-care treatments which produce high cure rates, low recurrence rates, and no scaring. This Stark III compliant service model enables Dermatologists and Plastic Reconstructive Surgeons to deliver better patient care, retain patient referrals and loyalties while increasing the value of their practice.

Vision

AlderMed service makes it possible for non-melanoma skin cancer patients to receive the highest possible cure rates, lowest recurrence rates, and no scaring all in the convenience of their clinician’s office. We improve the quality of care for the patient while improving the value of the clinician’s practice.

Values

• Enhancing our client’s reputation in their healthcare community will always be our number one priority.
• We will strive to exceed our clients’ expectations at all times.
• We will exhibit, at all times, the highest standards of integrity and ethical behavior.
• We will seek excellence in all we do, as excellence is our only acceptable standard.
• We will promote community value for all patients in the cancer care treatment processes we provide to our valued clients.
• Our services will always benefit the patients, clinicians and healthcare providers.
• Our employees will always be treated with integrity and a work environment that is safe, healthy, and self-empowering.

• Next >